 | |
Native name | 栄研化学株式会社 |
|---|---|
| Company type | Public KK |
| TYO: 4549 | |
| ISIN | JP3160700005 |
| Industry | Pharmaceutical |
| Founded | February 20, 1939 |
| Headquarters | Taito-ku, Tokyo, 110-8408 , Japan |
Area served | Worldwide |
Key people | Morifumi Wada (President and CEO) |
| Products |
|
| Revenue |  JPY 35 billion (FY 2017)
(US$ 315 million) (FY 2017) |
 JPY 2.6 billion (FY 2017)
(US$ 23.5 million) (FY 2017) | |
Number of employees | 659 (as of March 31, 2018) |
| Website | Official website |
| Footnotes / references [1][2] | |
Eiken Chemical (栄研化学株式会社, Eiken Kagaku Kabushiki-gaisha) is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment.
Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products.[3]
The company in 1998 developed the Loop-mediated isothermal amplification (LAMP) method, a nucleic acid amplification method, which is one of the most valuable tools in virtually all life science fields.[4]
- ^ "Corporate Profile". Eiken Chemical. Retrieved May 24, 2018.
- ^ "Company Profile". Nikkei Asian Review. Nikkei Inc. Archived from the original on August 1, 2020. Retrieved May 24, 2018.
- ^ "Bridge Report — Eiken Chemical (4549)". BRIDGE REPORT. Investment Bridge Co., Ltd. Retrieved May 25, 2018.
- ^ Gupta, Varsha; Sengupta, Manjistha; Prakash, Jaya; Tripathy, Baishnab Charan (October 22, 2016). Basic and Applied Aspects of Biotechnology. Springer Science+Business Media. p. 222. ISBN 978-981-10-0875-7.